These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 9421488)

  • 1. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
    D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
    J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of IL-12 p35 and p40 promoter activity by smokeless tobacco extract is associated with an effect upon activation of NF-kappaB but not IRF transcription factors.
    Petro TM
    Int Immunopharmacol; 2003 May; 3(5):735-45. PubMed ID: 12757742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
    Becker C; Wirtz S; Blessing M; Pirhonen J; Strand D; Bechthold O; Frick J; Galle PR; Autenrieth I; Neurath MF
    J Clin Invest; 2003 Sep; 112(5):693-706. PubMed ID: 12952918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
    Takeuchi A; Reddy GS; Kobayashi T; Okano T; Park J; Sharma S
    J Immunol; 1998 Jan; 160(1):209-18. PubMed ID: 9551973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappaB.
    Yoshimoto T; Nagase H; Ishida T; Inoue J; Nariuchi H
    Eur J Immunol; 1997 Dec; 27(12):3461-70. PubMed ID: 9464836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells.
    Chambers KA; Parks RJ; Angel JB
    Clin Exp Immunol; 2004 Aug; 137(2):329-40. PubMed ID: 15270850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells.
    Geldmeyer-Hilt K; Heine G; Hartmann B; Baumgrass R; Radbruch A; Worm M
    Biochem Biophys Res Commun; 2011 Apr; 407(4):699-702. PubMed ID: 21420936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-kappaB.
    Du C; Sriram S
    Cell Immunol; 2000 Jan; 199(1):50-7. PubMed ID: 10675275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines.
    Takeshita S; Gage JR; Kishimoto T; Vredevoe DL; Martínez-Maza O
    J Immunol; 1996 Apr; 156(7):2591-8. PubMed ID: 8786324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system.
    van Etten E; Verlinden L; Giulietti A; Ramos-Lopez E; Branisteanu DD; Ferreira GB; Overbergh L; Verstuyf A; Bouillon R; Roep BO; Badenhoop K; Mathieu C
    Eur J Immunol; 2007 Feb; 37(2):395-405. PubMed ID: 17274004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.
    Harant H; Lindley IJ
    Nucleic Acids Res; 2004; 32(17):5280-90. PubMed ID: 15466594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.
    Alroy I; Towers TL; Freedman LP
    Mol Cell Biol; 1995 Oct; 15(10):5789-99. PubMed ID: 7565732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide.
    Cowdery JS; Boerth NJ; Norian LA; Myung PS; Koretzky GA
    J Immunol; 1999 Jun; 162(11):6770-5. PubMed ID: 10352297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
    Dehbi M; Hiscott J; Pelletier J
    Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.